Pasithea Therapeutics Corp. ( KTTA) Oppenheimer 36th Annual Healthcare Life Sciences Conference February 26, 2026 4:00 PM EST ...
ArisGlobal, an AI-first technology company at the forefront of life sciences and creator of LifeSphere®, recently announced the launch of NavaX Translation, a new solution delivered through a ...
In a modest workshop space in West Dallas, a seventh-grade student has achieved a result usually associated with university laboratories. Aiden McMill.
Wave Life Sciences Ltd (NASDAQ:WVE) is one of the 13 Best Revenue Growth Stocks to Buy Right Now. On February 2, Wave Life Sciences Ltd. (NASDAQ:WVE) said it regained full rights to WVE-006, a ...
Convicted sex offender Jeffrey Epstein paid for genetic testing in an apparent bid to harness his own genetic material for regenerative medicine – which is aimed at repairing the body by developing ...
A promising pancreatic cancer therapy developed by Spanish scientist Mariano Barbacid has sparked global attention for its striking results in mice. B.
A genomic entrepreneur’s guide to the coming revolution in biology raises troubling questions about ethics and safety The prophet Ezekiel once claimed to have seen four beasts emerge from a burning ...
Did you know one of the largest collections of marine DNA in the entire world is hiding just outside D.C.? In today’s episode of “Matt About Town,” we’re taking an even deeper dive into the ...
Professor Jared Parrish spoke to BYU students on Jan. 15 about applying artificial intelligence and data science to maternal and child health. Parrish, a BYU alumnus turned maternal health ...
A Dalai Lama once said that our prime purpose in this life is to help others – and he may have been right. Scientists have found that having a positive impact on other people seems to be a key element ...
New study into ‘heritability’ shows that 50% of the variation in human lifespan could be down to genetics Some people who live to a great age put it down to an evening tot of whisky, others to staying ...
After two years of layoffs and funding pullbacks, South San Francisco’s life science industry is showing stronger signs of a comeback— though more mega-rounds and less early-stage funding could ...